Negative Pressure Wound Therapy Market to Reach USD 4.19 Billion by 2029 as Chronic Wounds and Advanced Wound Care Drive Adoption

Negative Pressure Wound Therapy Market Overview

The global Negative Pressure Wound Therapy Market was valued at USD 2.69 billion in 2021 and is expected to reach USD 4.19 billion by 2029, expanding at a CAGR of 5.7% during 2022–2029, according to Maximize Market Research. Negative pressure wound therapy (NPWT) is increasingly used for managing complex and hard-to-heal wounds by applying controlled negative pressure to the wound area, supporting fluid removal and the healing process. The rising prevalence of diabetes is a major market driver because diabetic patients are more vulnerable to chronic wounds and diabetic foot ulcers. An expanding elderly population is also increasing the incidence of chronic diseases, immobility, pressure ulcers, and other conditions requiring advanced wound management. Growing surgical volumes, increasing awareness of advanced wound-care technologies, and improvements in portable and single-use NPWT systems are creating additional opportunities. The shift toward outpatient and home-based wound management is particularly important because portable systems can reduce dependence on hospital infrastructure and support treatment closer to the patient. However, the cost of advanced NPWT equipment, reimbursement considerations, and the need for trained healthcare professionals can restrain adoption in some markets.

* Evaluate the Future Market Potential: https://www.maximizemarketresearch.com/request-sample/16699/ 

U.S. Market Trends and Investment in 2025

The United States remained a critical market for NPWT because of its high burden of chronic wounds, large elderly population, established healthcare infrastructure, and favorable reimbursement environment. Product innovation and government procurement were notable in 2025. Smith+Nephew reported that its Advanced Wound Devices business achieved 12.7% underlying revenue growth in the second quarter of 2025, with double-digit growth from its NPWT portfolio. The company also secured a contract with the U.S. Department of Defense worth up to $75 million over 10 years to supply its RENASYS TOUCH NPWT system, following a competitive tender process. The system was selected based on clinical efficacy and operational capabilities including portability, an intuitive interface, and multiple therapy modes. In addition, the FDA cleared Guard Medical's NPseal negative pressure wound therapy non-powered suction apparatus in April 2025, demonstrating continued development of NPWT technologies in the U.S. device market. These developments indicate continued investment in portable, efficient, and clinically supported wound-care technologies.

Market Segmentation: Largest-Share Segments

By Product, the Conventional NPWT segment held the leading position in the global market. Conventional NPWT systems have established clinical use across hospitals for treating complex wounds and continue to benefit from widespread adoption among healthcare professionals. Single-use NPWT represents an important growth opportunity as healthcare systems increasingly shift selected wound-care procedures toward outpatient and home-care settings.

By Wound Type, the MMR report evaluates diabetic foot ulcers, venous leg ulcers, pressure ulcers, and burn wounds. The increasing global incidence of diabetes and associated diabetic foot complications provides a significant demand base for NPWT. Aging populations and prolonged immobility additionally contribute to pressure and venous ulcers, broadening the addressable patient population.

By End User, Hospitals represent the leading segment. Hospitals manage a high volume of surgical, traumatic, chronic, and complex wounds and have the infrastructure and trained personnel required to administer advanced NPWT. At the same time, home-care settings are becoming increasingly important as portable systems make it possible to continue treatment outside traditional hospital environments.

Negative Pressure Wound Therapy Market Key players are:
• Acelity L.P., Inc.
• Smith & Nephew plc
• ConvaTec Group plc
• Mölnlycke Health Care AB
• Cardinal Health
• Medela AG
• Devon International Group (Devon Medical Products)
• ATMOS MedizinTechnik GmbH & Co. KG
• Talley Group Ltd.
• DeRoyal Industries, Inc.
• Wuhan VSD Medical Science & Technology Co., Ltd.
• Triage Meditech Pvt. Ltd.
• SunMed Medical
• The Wound Vac Company, LLC.
• Lohmann & Rauscher
• Genadyne
• PAUL HARTMANN.

Competitive Analysis

The MMR report identifies Acelity L.P., Inc., Smith & Nephew plc, ConvaTec Group plc, Mölnlycke Health Care AB, and Cardinal Health among the key companies operating in the global market. The report does not provide verified individual market-share percentages for these companies; therefore, exact company shares are not stated.

Acelity L.P., Inc. has historically been an important NPWT technology provider through the KCI V.A.C. platform. Its NPWT portfolio established a broad clinical footprint across hospitals and complex wound-care applications, contributing to the development and adoption of modern vacuum-assisted wound therapy.

Smith+Nephew is strengthening its NPWT position through its PICO and RENASYS portfolios. In 2025, the company reported double-digit growth in its NPWT portfolio and secured the U.S. Department of Defense contract for RENASYS TOUCH. Later 2025 clinical evidence involving more than 22,000 patients found that PICO single-use NPWT was associated with lower wound dehiscence, shorter hospital stays, and lower healthcare costs compared with the comparator system in cardiovascular and orthopedic surgery.

ConvaTec Group continues developing single-use NPWT through its Avelle platform and its newer ConvaVac development program. A 2025 clinical study evaluated Avelle for hard-to-heal wounds, while the company has emphasized combining a reliable negative-pressure pump with differentiated wound-dressing technology.

Mölnlycke Health Care continues expanding its NPWT offering through Avance Solo, a single-patient-use system designed for closed surgical incisions and open wounds. The Avance Solo Adapt system combines a pump, canister, foam, film, and transfer port, supporting portable wound management. The company also received a U.S. patent grant in 2025 covering an NPWT dressing incorporating a coupling member and tubing configuration.

Cardinal Health remains among the companies identified by MMR in the NPWT competitive landscape, with NPWT systems and associated wound-care products supporting healthcare providers. Its presence in the medical-supply ecosystem provides distribution and healthcare-provider access that can support continued adoption of advanced wound-care technologies.

Regional Analysis

United States: North America held the largest share of the global NPWT market in 2021, according to the MMR report, with the United States representing a major contributor. The country's high incidence of diabetes and chronic wounds, aging population, advanced healthcare infrastructure, and favorable reimbursement environment support adoption.

United Kingdom: The U.K. represents an important European market supported by established wound-care services and the National Health Service. NHS wound-care formularies include NPWT systems such as V.A.C. and Avelle for appropriate chronic, acute, traumatic, pressure, venous, diabetic, and surgical wounds, demonstrating continued clinical integration of the technology.

Germany: Germany's advanced hospital infrastructure, aging population, and emphasis on modern wound management create opportunities for NPWT adoption, particularly for chronic and postoperative wounds.

France: France benefits from established healthcare infrastructure and demand for advanced treatment approaches for chronic wounds and postoperative complications, supporting NPWT utilization.

Japan: Japan's rapidly aging population creates a significant need for chronic wound management and technologies capable of supporting efficient treatment. Advanced healthcare facilities and increasing emphasis on home and outpatient care can further support adoption.

China: China's large patient population, increasing diabetes burden, expanding healthcare infrastructure, and growing investment in medical technologies provide substantial long-term opportunities for NPWT manufacturers.

Related Reports: 

Personalized LASIK Surgery Market https://www.maximizemarketresearch.com/market-report/personalized-lasik-surgery-market/230753/ 

Venous Stents Market https://www.maximizemarketresearch.com/market-report/venous-stents-market/231857/ 

Aspergillosis Market https://www.maximizemarketresearch.com/market-report/aspergillosis-market/233535/ 

Conclusion

The global Negative Pressure Wound Therapy Market is projected to reach USD 4.19 billion by 2029, reflecting steady demand for advanced wound-management solutions. In our view, the strongest long-term opportunity lies in the transition from hospital-centered therapy toward portable, single-use, cost-effective, and digitally enabled NPWT systems. Rising diabetes, aging populations, surgical procedures, and chronic wounds will continue expanding the patient base, while clinical evidence demonstrating shorter hospital stays, reduced complications, and lower healthcare costs can accelerate adoption. Innovation in lightweight pumps, advanced dressings, pressure-control technologies, remote monitoring, and home-care delivery models is likely to remain a major factor shaping future market growth.

About Maximize Market Research

Maximize Market Research Pvt. Ltd. (MMR) is a global market research and consulting firm known for delivering accurate, actionable, and data-driven insights. Our expertise spans diverse industries — including medical devices, pharmaceuticals, technology, automotive, electronics, chemicals, personal care, and consumer goods. We provide services such as market-validated forecasts, competitive intelligence, strategic consulting, and industry impact analysis, helping businesses navigate market complexities and achieve sustainable growth.

Contact Maximize Market Research

MAXIMIZE MARKET RESEARCH PVT. LTD.
2nd Floor, Naval IT Park Phase 3,
Pune-Bangalore Highway, Narhe,
Pune, Maharashtra 411041, India.
📞 +91 9607365656
📧 sales@maximizemarketresearch.com